Medical Cannabis for PTSD in the UK
For patients who have not responded to established PTSD treatments, cannabis-based medicines may offer additional relief under specialist care.
Post-traumatic stress disorder (PTSD) is a serious mental health condition that can significantly impair daily functioning. For UK patients who have not responded adequately to established treatments, a medical cannabis prescription may be an option worth exploring with a specialist clinician.
What is PTSD?
PTSD develops in some individuals after experiencing or witnessing a traumatic event — such as military combat, sexual assault, serious accident, natural disaster, or prolonged abuse. The condition is characterised by intrusive re-experiencing of the trauma (flashbacks and nightmares), persistent avoidance of trauma-related reminders, negative alterations in mood and thinking, and heightened arousal and reactivity such as hypervigilance, irritability, and sleep disturbance.
PTSD affects people across all demographics in the UK — veterans, emergency service workers, survivors of violence, and civilians who have experienced significant trauma. It is associated with high rates of comorbid depression, anxiety, and substance misuse, and can severely disrupt relationships, employment, and quality of life.
Standard first-line treatments include trauma-focused cognitive behavioural therapy (TF-CBT), eye movement desensitisation and reprocessing (EMDR), and pharmacotherapy with SSRIs or SNRIs. While these approaches are effective for many patients, a proportion of individuals do not achieve adequate remission and continue to experience debilitating symptoms.
Medical Cannabis and PTSD — What Does the Evidence Say?
Research into cannabis-based medicines for PTSD has grown considerably over the past decade, drawing particularly on data from programmes in Canada, Israel, and certain US states. Clinical literature suggests that some patients with PTSD report reductions in nightmare frequency and severity, improved sleep quality, and reduced hyperarousal following the use of cannabis-based medicines.
The endocannabinoid system is thought to play a role in fear extinction and memory consolidation — processes that are disrupted in PTSD. Cannabis compounds, particularly THC and CBD, may interact with this system in ways that modulate the trauma response, though the precise mechanisms are still being investigated.
UK professional bodies have begun to acknowledge cannabis-based medicines as a consideration for patients who have not responded to established evidence-based therapies. Cannabis-based medicines for PTSD should be understood as a supplementary or last-resort option rather than a first-line treatment.
Who Qualifies for a Medical Cannabis Prescription for PTSD?
- Formal diagnosis: A confirmed diagnosis of PTSD or complex PTSD (CPTSD), ideally documented by a psychiatrist, psychologist, or GP.
- Failed conventional treatments: At least two recommended treatments tried — typically a combination of psychological therapy (TF-CBT or EMDR) and pharmacotherapy (SSRI) — without adequate and sustained symptom relief.
- Ongoing symptomatic burden: Persistent symptoms that significantly impair daily functioning despite treatment.
- Suitability assessment: Any substance misuse history will be considered by the specialist, as it may influence prescribing decisions.
- UK residency: You must be a UK resident.
PTSD Cannabis Treatment UK — The Private Prescription Pathway
There is no NHS pathway for cannabis prescribing for PTSD. Private specialist clinics under the UK unlicensed specialist prescribing framework are the standard route. Here is how PTSD cannabis treatment in the UK works in practice:
- Eligibility confirmation: You have a PTSD or complex PTSD (CPTSD) diagnosis and can document that at least two conventional treatments have been tried without adequate relief.
- Clinic selection: Choose a UK cannabis clinic with mental health prescribing experience. Clinics vary in their comfort with psychiatric presentations — those with psychiatrists or psychiatric nurses on their team are preferable for PTSD.
- Initial consultation: Typically a 30-60 minute video consultation. Fee: £79 to £200.
- Prescription: If appropriate, an initial prescription is issued — most commonly a CBD-dominant or balanced oil, often with low-dose THC introduced gradually.
- Ongoing monitoring: Regular follow-up appointments to assess symptom response and adjust dosing. PTSD prescribing requires more careful titration than purely physical conditions.
Which UK Clinics Treat PTSD?
PTSD and complex trauma presentations require clinics with mental health prescribing competence. The clinics most commonly accessed by UK PTSD patients include:
- Releaf — PTSD is one of their most frequently treated indications. The app-based model suits patients who find in-person settings difficult. From £79.
- Lyphe Clinic — has prescribed widely for PTSD, including veteran patients. Specialist access available. From £99.
- Zerenia Clinic — mental health conditions including PTSD. Psychiatry-led ethos. From £99.
- Mamedica — PTSD alongside other mental health and pain presentations. From £95.
- Sapphire Medical Clinics — specialist psychiatric assessment available. From £150.
Veterans and former emergency service workers with PTSD — see our guide on medical cannabis for veterans and PTSD in the UK for tailored information.
What to Expect from a Medical Cannabis Consultation for PTSD
Consultations for PTSD tend to be more detailed than those for purely physical conditions. The specialist will review your full mental health history, the nature of the traumatic event(s), your symptom profile, duration of illness, and all treatments tried to date. They will assess comorbidities and discuss how cannabis-based medicines might interact with your current medication regimen.
If prescribing is considered appropriate, specialists typically start at a low dose and titrate gradually. Products often include CBD-dominant formulations alongside carefully dosed THC, with attention to managing THC-related anxiety risk. Many PTSD patients access cannabis-based medicines as part of a broader care plan that continues to include psychological therapy.
How Much Does a Medical Cannabis Prescription for PTSD Cost in the UK?
- Initial consultation: £79 to £200. Clinics with psychiatric specialism may charge toward the higher end.
- Monthly medication: £100 to £400 per month.
- Follow-up appointments: £50 to £100 per session, typically monthly initially then less frequently as your condition stabilises.
Veterans and former emergency service personnel with PTSD may find that some charities and veteran support organisations can provide information about funding or subsidised pathways to medical cannabis treatment.
Frequently Asked Questions — Medical Cannabis for PTSD UK
- Is cannabis safe for people with PTSD who also have anxiety?
- THC can sometimes exacerbate anxiety symptoms. Many PTSD patients are started on CBD-dominant products or very low-THC formulations to manage this risk. Your specialist will assess carefully during the consultation.
- Can medical cannabis help with PTSD nightmares specifically?
- Some patients report improvements in nightmare frequency and sleep quality. Observational studies in other countries provide some support for this, though individual responses vary.
- Will using medical cannabis affect my ongoing therapy?
- It may complement psychological therapy, but this should be discussed openly with both your prescribing specialist and your therapist. Cannabis-based medicines are generally most appropriate as part of a broader treatment plan.
- I am a veteran with PTSD. Is there specific support available?
- Several UK cannabis clinics have experience working with veterans. Some veteran support charities may also be able to signpost you to appropriate clinical pathways.
- Can PTSD patients access medical cannabis on the NHS?
- NHS prescribing for PTSD remains extremely uncommon. Private specialist clinics currently represent the primary route for most patients in the UK.
Related conditions
The information on this page is provided for general educational purposes only and does not constitute medical advice. Eligibility for medical cannabis in the UK is determined by a licensed specialist on an individual clinical basis. Always consult a qualified healthcare professional about your own situation. Last reviewed: May 2026. Information is subject to change — always verify directly with a licensed clinic.